FDANews
www.fdanews.com/articles/86093-invitrogen-announces-preliminary-first-quarter-results

INVITROGEN ANNOUNCES PRELIMINARY FIRST QUARTER RESULTS

April 17, 2006

Invitrogen Corporation today announced preliminary results for its first quarter ended March 31, 2006. Revenues for the first quarter increased 12% to $309 million versus the same period last year. Sales were lower than anticipated by approximately 3% due to lower than expected performance in its US Bioproduction and Japan businesses. Revenue performance in Europe, US research, and emerging markets were strong.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=533748)